Erector Spinae Plane Block for Postoperative Analgesia for Laparoscopic Cholecystectomy

Postoperative Pain Clinical Trial

Official title:

The Effect of Erector Spinae Plane Block on Postoperative Pain Following Laparoscopic Cholecystectomy: A Randomized Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03420703
• Other study ID #: 2017-349
• Status: Completed
• Phase: N/A
• Start date: February 24, 2018
• Est. completion date: April 18, 2018

Study information

• Verified date: June 2018
• Source: Kocaeli University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Erector Spinae Plane Block is a newly defined regional anesthesia technique. Its use for many indications has been identified by case reports in the literature. As the investigators have considered that erector spinae plane block could be efficacious for providing postoperative analgesia in laparoscopic cholecystectomy, the investigators have implemented application of this blockade into practice at the clinic. Main purpose of this study is to evaluate the analgesic effect of ultrasound guided erector spinae block in laparoscopic cholecystectomy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: April 18, 2018
• Est. primary completion date: April 18, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 75 Years

Eligibility

Inclusion Criteria:

• 25 - 75 years of age

• ASA I - II

• Undergoing elective laparoscopic cholecystectomy

Exclusion Criteria:

• obesity

• ASA III - IV

• infection of the skin at the site of needle puncture area

• patients with known allergies to any of the study drugs

• coagulopathy

• recent use of analgesic drugs

Related Conditions & MeSH terms

• Pain, Postoperative
• Postoperative Pain

Intervention

Other:
• erector spinae plane block
ultrasound guided erector spinae plane block will be administered to this group.

Device:
• Intravenous morphine patient controlled analgesia device
Intravenous morphine patient controlled analgesia device will be given to the patients postoperatively and 24 hour morphine consumption will be recorded

Locations

Country	Name	City	State
Turkey	Kocaeli University Hospital	Izmit	Kocaeli

Sponsors (1)

Lead Sponsor	Collaborator
Kocaeli University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	24h morphine consumption	morphine consumptions for both group will be recorded	for postoperative 24 hour
Secondary	Postoperative nausea and vomiting	PONV after surgery was questioned	24 hour
Secondary	Pain	Numeric rating scales were recorded	24h